22 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Recommendations for Preventing ... or been newly diagnosed ... following initial diagnosis ... #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
marneffei Infections ... in HIV-AIDS Preventing ... 100 cells/mm3 g/mL ... #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Enteric Infections ... in HIV-AIDS Preventing ... if MIC<0.12 ug/ml ... #Treatment #management ... #HIVAIDS #pharmacology
Vancomycin Associated Acute Kidney Injury

 • Drug induced acute kidney injury is generally defined as a
increase of 44 mol ... • Treatment includes ... prevention by minimizing ... Vancomycin #AKI #pharmacology ... #toxicology #diagnosis
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
chew, or crush tablet ... suspension 4–6 mL ... mucosal #IDSA #Prevention ... opportunistic #infections ... #HIVAIDS #pharmacology
Summary of actions of some Cholinergic Agonists

Bethanechol 
• Used in treatment of urinary retention 
• Binds
of urinary retention ... urinary retention ... Edrophonium • Used for diagnosis ... Cholinergic #Agonists #Pharmacology ... #Table #Summary
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
Recommendations for Preventing ... Pre-Exposure Prevention ... health-care provider diagnosis ... , 2 doses (0.5 mL ... #HIVAIDS #pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
& Dry) is the treatment ... emphasis placed on prevention ... then placed on prevention ... #table #foamed ... icu #clinical #pharmacology
Cauda Equina Syndrome Overview

Cauda Equina Syndrome:
 • Prevalence: 1:33,000-100,000 ppl/yr
 • Incidence: 1.5-3.4 million ppl/yr
 •
lumbar spine • MCC ... Differential Diagnosis ... toon • Spinal infection ... T2 Treatment ... #causes #neurology
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
response preceding infection ... Paresthesias: Hands ... Guillain-Barre Diagnosis ... #management #treatment ... #neurology